Thomas Reardon has 1 portfolio company on record at Recent Funding. Its most recent investment on record is Synchron's $40M Series B+ round in June 2021, alongside University of Melbourne, Subversive Capital, Shanda Group and 6 others. That company is in Health and bio.

What Thomas Reardon invests in

• Health and bio · 1 · 100%
• Robotics and hardware · 1 · 100%
• Manufacturing and industrial · 1 · 100%

How Thomas Reardon invests

Share is of the 1 round on Recent Funding that name Thomas Reardon. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Thomas Reardon portfolio companies

• SSynchron$40MSeries B+ · Jun 2021

Most frequent co-investors

• KKhosla Ventures1 shared round · last Jun 3, 2021
• GGeneral Advance1 shared round · last Jun 3, 2021
• Rre.Mind Capital1 shared round · last Jun 3, 2021
• UUniversity of Melbourne1 shared round · last Jun 3, 2021
• NNeurotechnology Investors1 shared round · last Jun 3, 2021
• MMETIS innovative1 shared round · last Jun 3, 2021
• SSubversive Capital1 shared round · last Jun 3, 2021
• SShanda Group1 shared round · last Jun 3, 2021
• IID8 Investments1 shared round · last Jun 3, 2021

Similar investors

• AAccelia Capital1 company · 1 deal in 12 mo
• AAngel Academe1 company · 1 deal in 12 mo
• BBioGenerator Ventures1 company · 1 deal in 12 mo
• BBiospring Partners1 company · 1 deal in 12 mo
• CColossa Ventures1 company · 1 deal in 12 mo
• DDeepWork Capital1 company · 1 deal in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Thomas Reardon, which is a subset of its real portfolio. API: /api/v1/investors/thomas-reardon (get a free API key). More: the most active VC firms and new venture capital funds.